Cargando…

COVID-19 Vaccine Hesitancy Among Pregnant Women

Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alkhalifah, Manal, AlHusseini, Noara, McGhee, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382906/
https://www.ncbi.nlm.nih.gov/pubmed/37519564
http://dx.doi.org/10.7759/cureus.41126
_version_ 1785080779168022528
author Alkhalifah, Manal
AlHusseini, Noara
McGhee, John
author_facet Alkhalifah, Manal
AlHusseini, Noara
McGhee, John
author_sort Alkhalifah, Manal
collection PubMed
description Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to control it. With the introduction of vaccines, strategies need to be developed to prioritize high-risk populations to lower complication rates, hospitalization, and death. Pregnant women are considered a group of high-risk populations. Misinformation about the vaccination efficacy or side effects contributed to general hesitancy, especially among pregnant women. Purpose This study aims to describe the drivers of COVID-19 vaccine hesitancy among pregnant women in Saudi Arabia. Methodology This is a cross-sectional study among pregnant women in the OB/Gyn clinic in King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs (MNG-HA), using an online survey. Descriptive statistics (univariate analysis) was used to examine the population characteristics. The Chi-square test was used for categorical variables, and t-test for continuous variables. Further, we used the logistics regression model (multivariate analysis), adjusted for potential confounders, to examine factors associated with women's hesitancy to take the COVID-19 vaccine. All statistical tests were two-sided, and findings were considered statistically significant at p < 0.05. All analyses were conducted using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). Result The study included 303 pregnant women. Nearly half of the respondents had their vaccine during their pregnancy (42.24%), believing that the current vaccines' effectiveness for the coronavirus is good (41.25%). More than 73% of participants have received their COVID-19 vaccine before pregnancy. The mean hesitancy and anxiety score was 2 (agree), which concluded that the respondents were hesitant and anxious to receive the COVID-19 vaccine. Conclusion The study showed a significant correlation between pregnant women's worries and the intention to take the vaccine. The concerns were mainly about the impact of the vaccine on themselves, their babies, and the pregnancy.
format Online
Article
Text
id pubmed-10382906
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-103829062023-07-30 COVID-19 Vaccine Hesitancy Among Pregnant Women Alkhalifah, Manal AlHusseini, Noara McGhee, John Cureus Public Health Background COVID-19 has struck the world severely and caused much damage, losses, and a massive impact on different aspects of life. It is an airborne disease that spreads rapidly among populations and can cause severe illness or death. The rapid nature of its spread led to significant challenges to control it. With the introduction of vaccines, strategies need to be developed to prioritize high-risk populations to lower complication rates, hospitalization, and death. Pregnant women are considered a group of high-risk populations. Misinformation about the vaccination efficacy or side effects contributed to general hesitancy, especially among pregnant women. Purpose This study aims to describe the drivers of COVID-19 vaccine hesitancy among pregnant women in Saudi Arabia. Methodology This is a cross-sectional study among pregnant women in the OB/Gyn clinic in King Abdulaziz Medical City, Riyadh, Ministry of National Guard Health Affairs (MNG-HA), using an online survey. Descriptive statistics (univariate analysis) was used to examine the population characteristics. The Chi-square test was used for categorical variables, and t-test for continuous variables. Further, we used the logistics regression model (multivariate analysis), adjusted for potential confounders, to examine factors associated with women's hesitancy to take the COVID-19 vaccine. All statistical tests were two-sided, and findings were considered statistically significant at p < 0.05. All analyses were conducted using SAS statistical software version 9.4 (SAS Institute Inc., Cary, NC). Result The study included 303 pregnant women. Nearly half of the respondents had their vaccine during their pregnancy (42.24%), believing that the current vaccines' effectiveness for the coronavirus is good (41.25%). More than 73% of participants have received their COVID-19 vaccine before pregnancy. The mean hesitancy and anxiety score was 2 (agree), which concluded that the respondents were hesitant and anxious to receive the COVID-19 vaccine. Conclusion The study showed a significant correlation between pregnant women's worries and the intention to take the vaccine. The concerns were mainly about the impact of the vaccine on themselves, their babies, and the pregnancy. Cureus 2023-06-29 /pmc/articles/PMC10382906/ /pubmed/37519564 http://dx.doi.org/10.7759/cureus.41126 Text en Copyright © 2023, Alkhalifah et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Public Health
Alkhalifah, Manal
AlHusseini, Noara
McGhee, John
COVID-19 Vaccine Hesitancy Among Pregnant Women
title COVID-19 Vaccine Hesitancy Among Pregnant Women
title_full COVID-19 Vaccine Hesitancy Among Pregnant Women
title_fullStr COVID-19 Vaccine Hesitancy Among Pregnant Women
title_full_unstemmed COVID-19 Vaccine Hesitancy Among Pregnant Women
title_short COVID-19 Vaccine Hesitancy Among Pregnant Women
title_sort covid-19 vaccine hesitancy among pregnant women
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382906/
https://www.ncbi.nlm.nih.gov/pubmed/37519564
http://dx.doi.org/10.7759/cureus.41126
work_keys_str_mv AT alkhalifahmanal covid19vaccinehesitancyamongpregnantwomen
AT alhusseininoara covid19vaccinehesitancyamongpregnantwomen
AT mcgheejohn covid19vaccinehesitancyamongpregnantwomen